Publication | Closed Access
Baseline serum CXCL10 and IL-12 levels may predict severe asthmatics' responsiveness to omalizumab
22
Citations
24
References
2017
Year
InflammationAsthmaBaseline Serum Cxcl10AllergyAllergy MedicineImmunologyAllergenSevere AsthmaticsIl-12 LevelsMedicinePulmonary Disease
| Year | Citations | |
|---|---|---|
Page 1
Page 1